ArticleFrontiers in oncology2022

Pretreatment neutrophil to lymphocyte ratio as prognostic factor in metastatic breast cancer treated with cyclin dependent kinase 4/6 inhibitors.

Pauline Rottier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.